How Often Are Ozempic Injections Given?

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) is a GLP-1 receptor agonist typically injected once every seven days, making it a convenient option for people managing type 2 diabetes or pursuing weight loss goals. The medication works by slowing stomach emptying and signaling fullness to the brain, which reduces appetite and helps stabilize blood sugar levels. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies at a fraction of the brand-name cost, with dosing flexibility and personalized protocols available.

Standard Weekly Semaglutide Injection Schedule

Ozempic and most semaglutide formulations are given as a subcutaneous injection once per week on the same day each week. Patients typically start at a lower dose—such as 0.25 mg per week—to minimize nausea and other adjustment-period side effects. Over four to eight weeks, the dose is gradually increased under medical supervision until the patient reaches their target maintenance dose, which often ranges from 0.5 mg to 2.4 mg weekly depending on individual response and clinical goals.

The once-weekly schedule offers significant convenience compared to daily oral medications or more frequent injections. Most people use a pre-filled pen or syringe that they self-administer at home into the abdomen, thigh, or upper arm. Missing a dose by a day or two does not typically require doubling up; patients simply resume their regular schedule the following week.

Dose Escalation vs. Frequency: What Changes and What Doesn't

A common source of confusion is the difference between dose escalation and injection frequency. Frequency—how often you inject—remains at once weekly for standard semaglutide therapy. The dose, measured in milligrams, increases incrementally according to a titration schedule that your healthcare provider monitors. This stepwise approach allows your body to adapt and helps you tolerate the medication more comfortably.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Compounded Semaglutide vs. Brand-Name Ozempic Injection Schedules

Compounded semaglutide from licensed 503A pharmacies contains the identical active pharmaceutical ingredient as brand-name Ozempic and follows the same once-weekly injection schedule. The primary differences are cost, supply consistency, and customization options rather than dosing frequency or clinical timing. PlexusDx-supplied compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, making weekly therapy accessible without insurance or membership requirements.

Both compounded and brand formulations reach peak blood levels within one to three days of injection and maintain therapeutic levels throughout the seven-day interval. HSA and FSA accounts cover PlexusDx medications, providing additional tax-advantaged savings. Clinical studies show equivalent effectiveness between properly compounded semaglutide and the brand product when sourced from licensed 503A pharmacies with rigorous quality standards.

Factors That May Adjust Your Semaglutide Injection Plan

While injection frequency remains weekly, several factors may influence dose strength, titration speed, or injectable form choice: kidney function, liver health, personal tolerability, concurrent medications, and genetic predisposition to GLP-1 response. Some patients tolerate faster escalation schedules, while others benefit from slower progression to minimize gastrointestinal side effects. Your healthcare provider at PlexusDx reviews these variables before recommending a personalized protocol.

PlexusDx also offers oral semaglutide, the Microdose GLP-1 Protocol, and dual-compound injections like GLP-Squared for patients who need scheduling flexibility or have contraindications to standard weekly injections. The Precision Peptide Genetic Test identifies variants in GIPR and FTO, and MC4R genes that correlate with medication response, empowering your prescriber to choose the most effective regimen from the start.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How often do I inject Ozempic or semaglutide?

Standard semaglutide therapy requires one injection per week, administered on the same day each week. PlexusDx compounded semaglutide injections follow this identical once-weekly schedule and are $189/mo month-to-month, or from $149/mo on the 6-month plan, regardless of your current or future dose strength.

What happens if I miss a semaglutide injection by a few days?

Missing a weekly injection by one to two days is generally safe; simply inject as soon as you remember and resume your normal weekly schedule. Do not double-dose to catch up. If you consistently struggle with the weekly schedule, PlexusDx offers oral semaglutide or other formulations that may better fit your lifestyle.

Does semaglutide injection frequency change as my dose increases?

No. The frequency stays at once weekly throughout your entire treatment journey. Your dose strength may increase during the first four to eight weeks, but the number of injections remains one per week. PlexusDx pricing is flat per month, so dose increases do not raise your monthly cost.

Is compounded semaglutide injected on the same schedule as Ozempic?

Yes. Compounded semaglutide from licensed 503A pharmacies is injected once weekly, just like brand-name Ozempic. PlexusDx-supplied compounded semaglutide is chemically identical to the brand and offers the same weekly dosing schedule at significantly lower cost, with no insurance required.

How can I know if semaglutide is right for my body's response profile?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.